Scholarlink

<p>Aging is a main risk factor for the development of myocardial infarction (MI), with worse clinical outcomes. However, the understanding of age-related metabolic profiles in MI remains unclear. This study aimed to identify the clinical implications of age-specific metabolic phenotyping in the MI population. MI patients were classified into two categories as &gt; 65 years (<i>n</i> = 142) and ≤ 65 years (<i>n</i> = 139). Comprehensive metabolic profiles, including hydrophilic and lipid metabolites, were quantified and compared in MI patients aged &gt; 65 vs. ≤ 65 years. The primary clinical outcome was 3-year major adverse cardiac event (MACE), defined as the composite of cardiac death, non-fatal MI, and any revascularization. Overall, 88 aging-specific metabolites were identified in MI, specifying pathways of insulin resistance, lipolysis in adipocytes, and phenylalanine metabolism. Within the 3-year follow-up, 3-O-Methyldopa (3-OMD), Phenylacetyl-L-Glutamine (PAGln), Taurolithocholic acid (TLCA), and TG (10:0_16:0_18:1) were significantly associated with MACE. In multivariable analysis, 3-OMD (HR = 5.5, [95% CI 1.6–19.2], <i>p</i> = 0.007) and PAGln (HR = 3.8, [95% CI 1.3–11.4], <i>p</i> = 0.02) were the independent predictors of MACE. OCT examination was performed in the majority of MI patients (271/281, 96.4%); plaque rupture was diagnosed in 188 patients, and plaque erosion was identified in 77 patients. 3-OMD and PAGln were significant predictors of MACE in patients with plaque rupture but not in those with plaque erosion. In conclusion, in elderly MI patients, pathways of insulin resistance, lipolysis in adipocytes, and phenylalanine metabolism were activated. 3-OMD and PAGln indicate the poor clinical outcomes in MI patients with plaque rupture.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comprehensive age-specific metabolic phenotyping in myocardial infarction

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月7日

查看全文
  • Xiaoxuan Bai,
  • Ming Zeng,
  • Tianyu Wu,
  • Ying Lv,
  • Chen Zhao,
  • Xing Luo,
  • Boling Yi,
  • Huahui Ren,
  • Yixuan Zhang,
  • Liangxiao Xu,
  • Xiuzhu Weng,
  • Shan Zhang,
  • Yuxiao Zhu,
  • Sining Hu,
  • Bo Yu,
  • Haibo Jia

摘要

Aging is a main risk factor for the development of myocardial infarction (MI), with worse clinical outcomes. However, the understanding of age-related metabolic profiles in MI remains unclear. This study aimed to identify the clinical implications of age-specific metabolic phenotyping in the MI population. MI patients were classified into two categories as > 65 years (n = 142) and ≤ 65 years (n = 139). Comprehensive metabolic profiles, including hydrophilic and lipid metabolites, were quantified and compared in MI patients aged > 65 vs. ≤ 65 years. The primary clinical outcome was 3-year major adverse cardiac event (MACE), defined as the composite of cardiac death, non-fatal MI, and any revascularization. Overall, 88 aging-specific metabolites were identified in MI, specifying pathways of insulin resistance, lipolysis in adipocytes, and phenylalanine metabolism. Within the 3-year follow-up, 3-O-Methyldopa (3-OMD), Phenylacetyl-L-Glutamine (PAGln), Taurolithocholic acid (TLCA), and TG (10:0_16:0_18:1) were significantly associated with MACE. In multivariable analysis, 3-OMD (HR = 5.5, [95% CI 1.6–19.2], p = 0.007) and PAGln (HR = 3.8, [95% CI 1.3–11.4], p = 0.02) were the independent predictors of MACE. OCT examination was performed in the majority of MI patients (271/281, 96.4%); plaque rupture was diagnosed in 188 patients, and plaque erosion was identified in 77 patients. 3-OMD and PAGln were significant predictors of MACE in patients with plaque rupture but not in those with plaque erosion. In conclusion, in elderly MI patients, pathways of insulin resistance, lipolysis in adipocytes, and phenylalanine metabolism were activated. 3-OMD and PAGln indicate the poor clinical outcomes in MI patients with plaque rupture.

Graphical abstract